Document:

Unassociated Document

    
      Exhibit
10.6

      

      AMCOL
INTERNATIONAL CORPORATION

      AMENDED
AND RESTATED SUPPLEMENTARY PENSION PLAN FOR EMPLOYEES

      (AS
AMENDED AND RESTATED JANUARY 1, 2009)

    

     

    SECTION
1

     

    General

     

    1.1           Purpose and Effective
Date.  AMCOL International Corporation, formerly known as
American Colloid Company, a Delaware corporation (the “Company”), previously
established the AMCOL International Corporation Pension Plan (the “Plan”) to
provide retirement and other benefits for its eligible employees and those of
its affiliates which, with the consent of the Company, adopt the
Plan.  The Company and any such affiliate which adopts the Plan for
the benefit of its eligible employees are referred to below, collectively as the
“Employers” and individually as an “Employer.” The amount of the benefit payable
to or on account of an eligible employee under the Plan may be limited by reason
of the application of the provisions of Sections 401(a)(17) and 415(b) of the
Internal Revenue Code of 1986, as amended (the “Code”).  Such
limitations would be contrary to the intent of the Company in establishing the
Plan.  Therefore, the Company previously established the Supplementary
Pension Plan for Administrative Employees of American Colloid Company (the
“Supplementary Plan”), effective as of January 1, 1984, amended and restated it
effective as of October 1, 1995 and hereby amends and restates effective as of
January 1, 2009 (the “Effective Date”), to assure that affected individuals will
receive total retirement and other benefits in an amount equal to the amount
that they would have received under the Plan had Sections 401(a)(17) and 415(b)
of the Code not been enacted.  The Plan is intended to comply with
section 409A of the Code and the regulations thereunder.

     

    1.2           Definitions.  Unless
the context clearly requires otherwise, any word, term or phrase used in the
Supplementary Plan shall have the same meaning as is assigned to it under the
terms of the Plan.

     

    1.3           Supplementary  Plan  Administration;  Source  of
Benefit  Payments.  The authority to control and
manage the operation and administration of the Supplementary Plan shall be
vested in the retirement committee appointed by the Board of Directors of the
Company to act under the Plan.  In controlling and managing the
operation and administration of the Supplementary Plan, the retirement committee
shall have the same rights, powers and duties as those delegated to it under the
Plan.  The amount of any benefit payable under the Supplementary Plan
shall be paid from the general revenues of the Employer with respect to whose
former employee the benefit is payable.

     

    1.4           Applicable
Laws.  The Supplementary Plan shall be construed and
administered in accordance with the laws of the State of Illinois to the extent
that such laws are not preempted by the laws of the United States of
America.

     

    1.5           Gender and
Number.  Unless clearly inappropriate, words in any gender
shall include any other gender, and words in the singular shall include the
plural and vice versa.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    SECTION
2

     

    Participation

     

    2.1           Section
401(a)(17)  Supplementary Benefit.  Each eligible
employee of an Employer who retires on a retirement date under the Plan, and
each surviving spouse who becomes entitled to benefits under the Plan on account
of an eligible employee’s death after his retirement or while employed by an
Employer prior to his retirement, shall become a participant in this
Supplementary Plan as of the first date on which the amount of a benefit payable
to him under the Plan is limited by reason of the application of Section
401(a)(17) of the Code.  Notwithstanding the foregoing, an eligible
employee for Section 401(a)(17) supplementary benefits must be a member of a
select group of management or highly compensated employees, as provided in
Section 301(a)(3) of the Employee Retirement Income Security Act of 1974, as
amended.

     

    2.2           Section 415 Supplementary
Benefits.  Each eligible employee of an Employer who retires on
a retirement date under the Plan, and each surviving spouse who becomes entitled
to benefits under the Plan on account of an eligible employee’s death after his
retirement or while employed by an Employer prior to his retirement, shall
become a participant in the Supplementary Plan as of the first date on which the
amount of a benefit payable to him under the Plan is limited by reason of the
application of Section 415(b) of the Code.

     

    2.3           No Employment
Contract.  Establishment of this Supplementary Plan shall not
be construed to give any employee the right to be retained in an Employer’s
service or to any benefits not specifically provided in this Supplementary
Plan.

     

    SECTION
3

     

    Amount and Payment of
Supplementary Plan Benefit

     

    3.1           Amount of Section 401(a)(17)
Supplementary Benefit.  The Section 401(a)(17) supplementary
benefit payable under this Supplementary Plan to a participant as of any date
during any Supplementary Plan year shall be an amount equal to:

     

    (a)           the
amount of the benefit (expressed in the form of a single life annuity) that the
participant would have been entitled to receive under the Plan as of that date,
determined without regard to the limitations imposed by Section 401(a)(17) of
the Code;

     

    REDUCED
BY

     

    (b)           the
amount of the benefit that the participant would actually receive under the Plan
in the form of a single life annuity as of that date.

     

    3.2           Amount of Section 415
Supplementary Benefit.  The benefit payable under the
Supplementary Plan to a participant as of any date during any Supplementary Plan
year shall be an amount equal to:

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    (a)           the
amount of the benefit (expressed in the form of a single life annuity) that the
participant would have been entitled to receive under the Plan as of that date,
determined without regard to the limitations imposed by Section 415(b) of the
Code;

     

    REDUCED
BY

     

    (b)           the
amount of the benefit that the participant would actually receive under the Plan
in the form of a single life annuity as of that date.

     

    The
amount of benefits received hereunder shall be adjusted for early or postponed
commencement as provided in the Plan.

     

    3.3           Payment of Supplementary
Plan Benefit.  A participant’s Supplementary Plan benefit shall
be paid in the form of a single life annuity (50% joint and survivor annuity if
the participant is married), provided, however, that at any time prior to the
date payments are to commence under Section 4, a participant may elect to
receive his Supplementary Plan benefit in any of the standard or optional life
annuity forms of benefit under the Plan, other than a joint and survivor annuity
upon marriage or remarriage after the annuity starting date.  Any such
alternate form of benefit shall be the actuarial equivalent of the benefit
calculated under sections 3.1 and 3.2 as determined by the Plan’s actuary based
on the actuarial assumptions used for determining equivalent benefits under the
Plan on the date benefits commence.  A participant’s Supplementary
Plan benefit will be paid to him monthly on the dates and for the period during
which benefits would be payable to him under the Plan in the form selected
hereunder.

     

    3.4           Distributions to Persons
Under Disability.  In the event a participant is declared
incompetent and a conservator or other person legally charged with the care of
his person or of his estate is appointed, any benefits to which such participant
is entitled under the Supplementary Plan shall be paid to such conservator or
other person legally charged with the care of his person or of his
estate.

     

    3.5           Benefits May Not be Assigned
or Alienated.  The benefits payable to any participant under
the Supplementary Plan may not be voluntarily or involuntarily assigned or
alienated.

     

    3.6           Successors.  This
Supplementary Plan shall be binding upon any assignee or successor in interest
to any Employer, whether by merger, consolidation or the sale of substantially
all of the Employer’s assets.

     

    SECTION
4

     

    Commencement of
Supplementary Plan Benefit

     

    4.1           Normal
Retirement.  If a participant has reached his Normal Retirement
Date under the Plan, his Supplementary Plan benefits shall commence with the
first month following his “separation from service,” within the meaning of
section 409A of the Code.

     

    4.2           Early
Retirement.  If a participant has not reached his Normal
Retirement Date under the Plan, but has reached his Early Retirement Date under
the Plan, his Supplementary Plan benefits shall commence with the first month
following his “separation from service” within the meaning of section 409A of
the Code.

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    4.3           Disability
Retirement.  If a participant has not reached his Normal
Retirement Date or Early Retirement Date under the Plan, but has reached his
Disability Retirement Date under the Plan, his Supplementary Plan benefits shall
commence on the first day of the month following the later of his Disability
Retirement Date or the date he becomes disabled within the meaning of section
409A of the Code.

     

    4.4           Deferred Vested
Pension.  If a participant has not reached his Normal
Retirement  Date, Early Retirement Date or Disability Retirement Date,
but has met the requirements for a Deferred Vested Pension under the Plan, his
Supplementary Plan benefits will commence with the first month following the
later of the date he has separated from service within the meaning of section
409A of the Code or the date on which the sum of his Period of Service under the
Plan and his age is equal to 70.

     

    4.5           Death
Benefits.  If the participant dies prior to commencement of
benefits hereunder and meets the requirements for a Pre-Retirement Spouse’s
Death Benefit under the Plan, his spouse shall be entitled to receive a benefit
equal to the difference between the Pre-Retirement Spouse’s Death Benefit the
spouse would have been entitled to receive under the Plan without regard to the
limitations imposed by Sections 401(a)(17) and 415(b) of the Code and the
Pre-Retirement Spouses’ Death Benefit the spouse would actually receive under
the Plan as of the date of the Participant’s death.  The
Pre-Retirement Spouse’s Death Benefit shall be payable monthly to the spouse
commencing as of the first day of the calendar month following the month in
which the participant died, and ceasing with the last payment for the month in
which the spouse dies.

     

    4.6           Six-Month
Delay.  Notwithstanding the foregoing, no benefits under this
Supplementary Plan shall be paid to a “specified employee” within the meaning of
Code section 409A(a)(2)(B)(i) until the seventh month following the month of the
Participant’s “separation from service” within the meaning of section 409A of
the Code.  Any payments that would have been paid if not for this
section 4.6 shall be accumulated and paid in full in the seventh month following
the month of the participant’s “separation from service” together with interest
at the short term applicable federal rate as in effect on the date of
“separation from service.”

     

    4.7           Separation from
Service.  Payments and benefits hereunder upon Employee’s
termination or severance of employment with the Company that constitute deferred
compensation under Code Section 409A shall not be paid prior to Employee’s
“separation from service” within the meaning of Code Section 409A.

     

    SECTION
5

     

    Amendment and
Termination

     

    The
Company may at any time, by resolution of its Board of Directors, amend or
terminate the Supplementary Plan.  Any Employer may terminate the Plan
at any time, as applied to employees of that Employer, by resolution of its
Board of Directors.  However, such an amendment or termination of the
Supplementary Plan shall not:

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    (a)           reduce
or impair the interests of participants in benefits being paid under the
Supplementary Plan as of the date of amendment or termination, as the case may
be, or

     

    (b)           reduce
the aggregate amount of benefits subsequently payable to any participant under
the Plan and the Supplementary Plan to an amount which is less than the amount
that would have been payable if the employee had retired immediately prior to
the date of such amendment or termination, as the case may be.

    

    IN
WITNESS WHEREOF, the Company has signed this Plan document as of December 18,
2008.

     

    
      
        
          
            	
                    AMCOL International
Corporation,

                  
	
                    a
      Delaware corporation

                  
	 
      	 
      
	
                    By: /s/ James Ashley

                  
	
                    Title:
      Secretary

                  

          

        

      

    

    
      
         

      

      
        5Unassociated Document

     

    AGREEMENT

     

    THIS
AGREEMENT (this “Agreement”) dated as of March 13, 2009 by and among Lawrence S.
Coben (“Coben”), Ronald D. Ormand (“Ormand”), Jon Schotz (“Schotz”), Charles A.
Norris (“Norris”), Stephen N. Casati (“Casati”), Bill Goldstein, Olympus Capital
Investment, LLC, Jerry Doren, Owen Coleman, Bill Armstrong, Trevor Wilson, Brian
McInerney, Richard Kassar, David Levine, Jim Land, David A. Preiser, Gary C.
Evans and Jonathan Jacobs (individually a “Seller” and collectively, the
“Sellers”), SoftForum Co., Ltd. and Sang-Chul Kim (individually, an “Investor”
and collectively, the “Investors”) and Tremisis Energy Acquisition Corporation
II, a Delaware corporation (the “Company”).

     

    RECITALS

     

    The
Company was formed on July 3, 2007 for the purpose of acquiring an operating
business (“Business Combination”).

     

    Sellers
collectively own an aggregate of 2,650,000 warrants to purchase shares of common
stock, par value $0.0001 per share (the “Common Stock”), of the Company (the
“Warrants”).  In addition, Sellers collectively own an aggregate of
2,433,168 shares (the “Shares”) of Common Stock of the Company.

     

    Coben,
Ormand, Casati, Shotz and Norris are officers and/or directors of the
Company.

     

    The
Investors have approached the Company and the Sellers with a proposal to take
control of the Company’s Board of Directors, use their best efforts to introduce
the Company to suitable targets for a Business Combination and in consideration
therefor to obtain the right to purchase the Warrants.

     

    The
Company’s Board of Directors has determined that the Investors offer the Company
the best chance to consummate a Business Combination and that it is in the best
interests of the Company’s stockholders to enter into this
Agreement.

     

    Pursuant
to this Agreement, the Sellers will have the option to sell to the Investors and
the Investors will have the option to purchase from the Sellers all of the
Warrants upon the earlier of (i) the Company’s consummation of a Business
Combination, (ii) the Company’s liquidation of its trust account and (iii)
December 31, 2009, all upon the terms and subject to the conditions set forth in
this Agreement.

     

    As a
condition to this Agreement, and in consideration of Investors’ efforts in
assisting the Company to consummate a Business Combination, upon consummation of
a Business Combination, the Sellers shall transfer, for no additional
consideration, an aggregate of 2,333,168 shares of Common Stock to Investors, in
the amount set forth next to each Investor’s name as set forth on Schedule 2.3 attached
hereto.

     

    
      
        
        

      

      
        1

        
          

        

      

      
        
        

      

    

     

    AGREEMENT

     

    For good
and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties agree as follows:

     

    ARTICLE
1

     

    DEFINITIONS

     

    The
following terms, as used herein, have the following meanings:

     

    “1933
Act” means the Securities Act of 1933, as amended.

     

    “1934
Act” means the Securities Exchange Act of 1934, as amended.

     

    “Affiliate”
means any Person that, directly or indirectly through one or more
intermediaries, controls or is controlled by or is under common control with a
Person, as such terms are used in the 1933 Act and the rules and regulations
promulgated thereunder.

     

    “Business
Day” means any day other than a Saturday, Sunday or legal or bank holiday in the
City of New York, State of New York.  If any time period set forth in
this Agreement expires on other than a Business Day, such period shall be
extended to and through the next succeeding Business Day.

     

    “Common
Stock” has the meaning set forth in the Preamble.

     

    “Company
SEC Documents” means all documents, as such documents may have been amended
(and, if amended, only the most recent form of such document shall be deemed to
be one of the “Company SEC Documents”), filed by the Company with the SEC under
either the 1933 Act or the 1934 Act since its formation.

     

    “Indemnified
Damages” has the meaning set forth in Section
6.1.

     

    “Investors”
has the meaning set forth in the Preamble.

     

    “Lien”
means, with respect to any property or asset, any mortgage, lien, pledge,
charge, security interest, encumbrance or other adverse claim of any kind in
respect of such property or asset, other than (i) Liens created by Investors and
(ii) restrictions on transfer pursuant to securities laws, the Share Escrow
Agreement or the Subscription Agreement.  For purposes of this
Agreement, a Person shall be deemed to own subject to a Lien, any property or
asset that it has acquired or holds subject to the interest of a vendor or
lessor under any conditional sale agreement, capital lease or other title
retention agreement relating to such property or asset.

     

    “Option
Trigger” means the earlier of (i) the Company’s consummation of a Business
Combination, (ii) the Company’s liquidation of its trust account and (iii)
December 31, 2009.

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    “Person”
means an individual, corporation, partnership, limited liability company,
association, trust or other entity or organization, including a government or
political subdivision or an agency or instrumentality thereof.

     

    “Purchase
Price” has the meaning set forth in Section
3.1.

     

    “Put/Call
Escrow Agent” has the meaning set forth in Section
2.1.4.

     

    “SEC”
means the Securities and Exchange Commission.

     

    “Seller”
and “Sellers” has the meaning set forth in the Preamble.

     

    “Share
Escrow Agent” means Continental Stock Transfer and Trust Company.

     

    “Share
Escrow Agreement” has the meaning set forth in Section
3.2.5.

     

    “Subscription
Agreement” is the agreement executed by each Seller in connection with the
purchase of his Warrants.

     

    “Warrants”
has the meaning set forth in the Preamble.

     

    Any
reference in this Agreement to (i) a statute shall be to such statute, as
amended from time to time, and to the rules and regulations promulgated
thereunder and (ii) the word “including” shall mean “including, without
limitation.”

     

    ARTICLE
2

     

    PUT
AND CALL OPTIONS; TRANSFERS

     

     2.1.           Put
and Call Options for Purchase and Sale of Warrants.

     

    2.1.1  Grant of Put
Option.  The Investors hereby grant to the Sellers an
irrevocable option (the “Put Option”) to require Investors to purchase all, but
not less than all, of the Warrants at the Purchase Price, which Put Option may
be exercised by the Sellers only following the Option Trigger.  The
Put Option shall be terminated and be of no further force or effect in the event
that Sellers are in breach of or default of the representations and warranties
contained in Section
4.6 of this Agreement.

     

    2.1.2  Grant of Call
Option.  Sellers, jointly and severally, hereby grant to the
Investors an irrevocable option (the “Call Option”; the Call Option and the Put
Option shall sometimes be referred to herein as an “Option”) to purchase at any
time following the Option Trigger, all, but not less than all, of the Warrants
at the Purchase Price.

     

    2.1.3  Exercise of Option.
The Investors or the Sellers, as applicable, may exercise an Option following
the Option Trigger by delivering written notice of exercise to the Sellers or
the Investors, as applicable, and in either case to the Put/Call Escrow
Agent.  Sellers’ written notice of exercise of their Put Option need
be executed only by either Coben or Ormand (and all Sellers will be bound by
it).  The closing of the purchase and sale of the Warrants pursuant to
such an exercise of an Option (the “Closing”) will occur within two (2) business
days following the delivery of such notice of exercise. At the Closing, (i) the
Put/Call Escrow Agent will deliver to the Investors the certificates
representing the Warrants being purchased by the Investors, which shall be
transferred by the Sellers free and clear of all Liens, together with the
warrant powers related thereto referenced below in Section 3.2.1 and
(ii) the Put/Call Escrow Agent will deliver the Purchase Price to the Sellers.
The payment shall be made by immediately available funds transferred to a bank
account designated by the Sellers to the Put/Call Escrow Agent prior to
Closing.  Upon receipt of the Purchase Price, the Sellers hereby
acknowledge that they will have no further interest in the
Warrants.

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    2.1.4  Put/Call Escrow. On
the date of this Agreement, (i) the Investors shall deposit the Purchase Price
by wire transfer to an interest-bearing escrow account maintained by Graubard
Miller (“Put/Call Escrow Agent”); and (ii) the Sellers shall deposit the
Warrants and the warrant powers with the Put/Call Escrow Agent.  The
Purchase Price, Warrants and warrant powers shall be held in escrow by the
Put/Call Escrow Agent until the exercise of an Option, pursuant to an escrow
agreement dated the date hereof (“Put/Call Escrow Agreement”).

     

     2.2.           Transfer of
Shares.  Upon consummation of a Business Combination, Sellers
shall transfer an aggregate of 2,333,168 of the Shares (such Shares referred to
herein as the “Transferred Shares”) to Investors, in the amount set forth next
to such Seller’s name as set forth on Schedule 2.2 attached
hereto, which Transferred Shares shall continue to be held in escrow pursuant to
the Share Escrow Agreement.  Sellers have delivered duly executed
stock powers and a notice to the Share Escrow Agent evidencing the agreement of
the Sellers set forth herein.  The Sellers will receive no cash
consideration for the transfer of the Transferred Shares to the
Investors.

     

    ARTICLE
3

     

    PURCHASE
PRICE; DELIVERIES

     

     3.1.           Purchase
Price.  The consideration to be paid by Investors to Sellers
for the Warrants pursuant to the exercise of an Option shall be an aggregate
purchase price of $2,100,000, subject to reduction dollar for dollar by the
amount in the Company’s operating bank account on the date hereof less than
$340,000 (the “Purchase Price”), to be paid after the exercise of an Option to
each Seller in the amounts as set forth on Schedule
3.1.

     

     3.2.           Deliveries by Sellers,
Investors and Company. Sellers, Investors or the Company, as the case may
be, shall deliver on the date hereof:

     

    3.2.1           Warrants
and duly executed warrant powers with respect to the Warrants, which shall be
held in escrow by the Put/Call Escrow Agent until their release upon the
exercise of an Option;

     

    3.2.2           Amendments
to the insider letters previously executed by each Seller, in the form of Exhibits A-1 through
A-2
hereto.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    3.2.3           An
executed letter agreement addressed to the Share Escrow Agent, in the form
attached hereto as Exhibit B, with
respect to the transfer of the Transferred Shares upon the consummation of a
Business Combination, along with appropriate stock powers to effectuate
same;

     

    3.2.4           Resignations
as director and officer of the Company from Lawrence S. Coben, resignation as
President of the Company from Ronald D. Ormand, and resignations as directors of
the Company from Stephen N. Casati, Jon Shotz and Charles A.
Norris;

     

    3.2.5           Insider
letters, in the form attached hereto as Exhibits C-1 through
C-2, for each of the Investors (which shall include trust fund indemnity
provisions and an acknowledgement by each Investor to become a party to the
share escrow agreement (“Share Escrow Agreement”) with respect to his
Transferred Shares);

     

    3.2.6           A
notice to the Company from the Sellers, in the form attached hereto as Exhibit D, with
respect to the assignment of Sellers’ registration rights with respect to the
Warrants, the shares of Common Stock underlying the warrants and the Transferred
Shares;

     

    3.2.7           An
executed letter agreement, in the form attached hereto as Exhibit E,
terminating the Company’s use of office space, administrative, technology and
secretarial services, at 2925 Briarpark, Houston, Texas;

     

    3.2.8           Irrevocable
proxies with respect to voting of the Shares at a meeting of stockholders for
the purpose of electing directors;

     

    3.2.9           A
certificate, signed by Coben, Ormand and the Chief Executive Officer of the
Company, that (i) the Company has extinguished any and all liabilities, except
for the liabilities set forth on Schedule 3.2 attached
hereto and such liabilities known to the signatories as would not, when paid,
reduce the Company’s out of trust cash balance below $315,000, (ii) the Company
has a cash balance in its operating bank account outside of the trust account
for working capital purposes of no less than $340,000, and (iii) the Company has
not executed any definitive agreements, letters of intent or any other agreement
or understanding with respect to any Business Combination which has not been
abandoned prior to the date hereof;

     

    3.2.10         A
certificate, signed by the Chief Executive Officer of the Company, attaching
resolutions adopted by the remaining directors following the resignations
described in Section
3.2.4 hereto which (i) elect Sang-Chul Kim, David Jin Yoo, Seung Jung Ro
and Jhong Won Kim as directors of the Company to fill the vacancies created by
such resignations and (ii) appoint Sang-Chul Kim as Chairman and Co-Chief
Executive Officer, Ronald D. Ormand as Co-Chief Executive Officer, and Yeon-su
Kim as Secretary of the Company, respectively;

     

    3.2.11         An
opinion of Graubard Miller in form and substance reasonably acceptable to
Investors and an opinion of Mintz Levin in form and substance reasonably
acceptable to the Company;

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    3.2.12         The
Put/Call Escrow Agreement; and

     

    3.2.13         Such
other certificates, instruments and documents of transfer, if any, as may be
necessary to consummate the transactions contemplated by this
Agreement.

     

    ARTICLE
4

     

    REPRESENTATIONS
AND WARRANTIES OF SELLERS

     

    Each of
the Sellers, severally and jointly (except for Sections 4.1, 4.4(b), 4.5(b),
4.6, 4.10(b) and 4.15(b) (“Several Provisions”), which shall be made only
severally), makes the representations and warranties contained in this Article 4
to Investors, intending that Investors rely on each of such representations and
warranties in order to induce Investors to enter into and complete the
transactions contemplated by this Agreement.

     

     4.1.           Authorization of
Sellers. The execution, delivery and performance by each Seller of this
Agreement and the consummation by each Seller of the transactions contemplated
hereby are within each Seller's powers and have been duly authorized by all
necessary action on the part of such Seller. This Agreement constitutes a valid
and binding agreement of each Seller, enforceable against each Seller in
accordance with its terms.

     

     4.2.           Company
Authorization. This Agreement is the valid and binding obligation of the
Company, enforceable in accordance with its terms.  The execution,
delivery and performance of this Agreement has been duly authorized by all
necessary corporate or other action of the Company.  The issuance,
sale and delivery of the shares of Common Stock issuable upon exercise of the
Warrants have been duly authorized and reserved for issuance by all necessary
corporate action on the part of the Company.  The shares of Common
Stock issuable upon exercise of the Warrants, when issued, will be duly and
validly issued, fully paid and non-assessable.

     

     4.3.           Corporate Existence and
Power.  The Company is a corporation duly incorporated, validly
existing and in good standing under the laws of the State of Delaware and has
all corporate powers and all governmental licenses, authorizations, permits,
consents and approvals required to carry on its business as now
conducted.  The Company is duly qualified to do business as a foreign
corporation and is in good standing in each jurisdiction where such
qualification is necessary.

     

     4.4.           Governmental
Authorization. The execution, delivery and performance of this Agreement
and the consummation of the transactions contemplated hereby by (a) the Company
and (b) each Seller, require no action by or in respect of, or filing with, any
governmental body, agency, official or authority, domestic or foreign, other
than compliance with any applicable requirements of the 1933 Act, the 1934 Act
and any other applicable securities laws, whether state, federal or
foreign.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

     4.5.           Non-contravention.
The execution, delivery and performance of this Agreement and the consummation
of the transactions contemplated hereby by (a) the Company and (b) each Seller,
do not and will not (i) contravene, conflict with, or result in a violation or
breach of any provision of the certificate of incorporation or by-laws of the
Company or any applicable law, statute, ordinance, rule, regulation, judgment,
injunction, order or decree binding upon or applicable to such Seller or the
Company, (ii) except as set forth in Schedule 4.5,
contravene, conflict with, or result in a violation or breach of any provision
of any written or oral agreement to which the Company or any Seller is a party,
(iii)  except as set forth in Schedule 4.5, require
any consent or other action by any Person under, constitute a default or an
event that, with or without notice or lapse of time or both, could become a
default under, or cause or permit the termination, cancellation, acceleration or
other change of any right or obligation or the loss of any benefit to which the
Company or any Seller is entitled under any provision of any agreement or other
instrument binding upon the Company or any Seller or any license, franchise,
permit, certificate, approval or other similar authorization affecting the
assets or business of any Seller or the Company, or (iv) result in the creation
or imposition of any Lien on the Warrants or shares of Common Stock underlying
the Warrants.

     

     4.6.           Title to Warrants and
Shares. Subject to the terms and provisions of the Share Escrow Agreement
and Subscription Agreement, each Seller has good and valid legal title to, and
beneficial ownership of, the respective Shares and Warrants owned by him and
full legal right and power to transfer and deliver the Transferred Shares and
Warrants owned by him to Investors in the manner provided in this Agreement.
Upon payment of the Purchase Price for the Warrants pursuant to the terms of
this Agreement and the transfer of the Transferred Shares, Investors will
receive good and valid legal title to, and full beneficial ownership of, the
Warrants and Transferred Shares owned by such Seller, free and clear of all
Liens, subject to the terms and provisions of the Share Escrow Agreement and the
Subscription Agreement.

     

     4.7.           Capitalization. The
authorized capital stock of the Company consists of 35,000,000 shares of Common Stock,
par value $0.0001 per share, 12,165,837 of
which shares are issued and outstanding, and 1,000,000 shares of preferred
stock, none of which shares are issued and outstanding.  All of the
issued and outstanding shares of the Company’s capital stock have been duly
authorized and validly issued and are fully paid and non-assessable and have
been issued in compliance with applicable Federal and state securities
laws.  Except as contemplated by this Agreement or as disclosed in the
Company SEC Documents (i) no subscription, warrant, option, convertible security
or other right (contingent or otherwise) to purchase or acquire any shares of
capital stock of the Company is authorized or outstanding, (ii) there is not any
commitment or offer of the Company to issue any subscription, warrant, option,
convertible security or other such right or to issue or distribute to holders of
any shares of its capital stock any evidences of indebtedness or assets of the
Company, (iii) the Company has no obligation (contingent or otherwise) to
purchase, redeem or otherwise acquire any shares of its capital stock or any
interest therein or to pay any dividend or make any other distribution in
respect thereof, and (iv) there are no restrictions on the transfer of the
Company’s capital stock other than those arising from securities laws or
contemplated in the Company SEC Documents.  Except as set forth in
this Agreement or in the Company SEC Documents, no Person is entitled to (i) any
preemptive or similar right with respect to the issuance of any capital stock of
the Company, or (ii) any rights with respect to the registration of any capital
stock of the Company under the 1933 Act.

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

     4.8.           SEC
Filings.   As of its filing date, as any such filing may
have been amended prior to the date hereof, each Company SEC Document complied,
as to form and content in all material respects with the applicable requirements
of the 1933 Act and the 1934 Act, as the case may be, and did not contain any
untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements made therein, in the light of the circumstances
under which they were made, not misleading.

     

     4.9.           No Undisclosed Material
Liabilities. Since September 30, 2008, there has been no material change
in the financial condition of the Company.  Except as disclosed in the
Company SEC Documents, there are no material liabilities or obligations of the
Company of any kind whatsoever, whether accrued, contingent, absolute,
determined, determinable or otherwise, other than liabilities or obligations
incurred in the ordinary course of business consistent with past practices since
September 30, 2008 or in connection with
the transactions contemplated hereby.

     

     4.10.        
Litigation.  There
is no litigation or other administrative or judicial proceedings pending or
threatened against (a) the Company or (b) that might endanger each Seller’s
right to sell the Warrants owned by him to Investors or to transfer the
Transferred Shares owned by him to the Investors. There are no judgments against
(a) the Company or (b) against any Seller that might endanger such Seller’s
right to sell the Warrants owned by him or to transfer the Transferred Shares
owned by him to the Investors in accordance with the terms of this
Agreement.

     

     4.11.        
Employment, Consulting
and Other Agreements.  No Seller nor any Affiliate of any
Seller is a party to any employment agreement or consulting agreement with the
Company, or to any other agreement which entitles such Seller or any of his
Affiliates to payments from the Company.

     

     4.12.         Repayment of Loans.
Each Seller hereby confirms that all loans made by him or his Affiliates to the
Company and/or its Affiliates have been satisfied in full and no such Seller is
due any further amounts from the Company or its Affiliates for any
purpose.

     

     4.13.         Possession of Company
Property.  Except as set forth on Schedule 4.13, no
Seller is in possession of any Company property.

     

     4.14.         No Other Company
Agreements.  No Seller has entered into any agreements on
behalf of the Company except such agreements as have been fully performed or
agreements that have been filed by the Company as exhibits to the Company SEC
Documents.

     

     4.15.         Finders’ and Advisory
Fees.  There is no investment banker, broker, finder or other
intermediary that has been retained by or is authorized to act on behalf of (a)
the Company or (b) any Seller, who might be entitled to any fee or commission
from the Company or any Seller in connection with the transactions contemplated
in this Agreement.

     

     4.16.         Recent Financial
Transactions.  Attached hereto as Schedule 4.16 is a
ledger of all payments made by the Company between September 30, 2008 and March
3, 2009.  This ledger was prepared from the books and records of the
Company and represents all payments made by the Company during this time
period.

     

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    ARTICLE
5

     

    REPRESENTATIONS
AND WARRANTIES OF INVESTORS

     

    Investors
severally make the representations and warranties contained in this Article 5 to
the Company and Sellers intending that the Company and Sellers rely on each of
such representations and warranties in order to induce the Company and Sellers
to enter into and complete the transactions contemplated by this
Agreement.

     

     5.1.           Authorization. The
execution, delivery and performance by Investors of this Agreement and the
consummation by Investors of the transactions contemplated hereby are within
Investors’ power and have been duly authorized by all necessary action. This
Agreement constitutes a valid and binding agreement of Investors, enforceable
against Investors in accordance with its terms.

     

     5.2.           Governmental
Authorization. The execution, delivery and performance by Investors of
this Agreement and the consummation by Investors of the transactions
contemplated hereby require no action by or in respect of, or filing with, any
governmental body, agency, official or authority, domestic, or foreign, other
than compliance with any applicable requirements of the 1933 Act, the 1934 Act
and any other applicable securities laws, whether state, federal or
foreign.

     

     5.3.           Investment
Representations.

     

    5.3.1  Acknowledgment.  Each
Investor understands and agrees that the Warrants, the shares of common stock
underlying the Warrants and the Transferred Shares have not been registered
under the Securities Act or the securities laws of any state of the U.S. and
that the sale of the Warrants and the transfer of the Transferred Shares will be
effected in reliance upon one or more exemptions from registration afforded
under the 1933 Act.

     

    5.3.2  Status.  Each
Investor represents and warrants to Sellers that such Investor is an “Accredited
Investor” as defined in the rules promulgated under the 1933
Act.  Each Investor severally understands that the Warrants will be
offered and sold to such Investor and the Transferred Shares transferred to such
Investor in reliance upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of such Investor set
forth in this Agreement, in order that the Sellers may determine the
applicability and availability of the exemptions from registration on which
Sellers are relying.

     

    5.3.3  Opinion.  No
Investor will transfer any or all of the Warrants or Transferred Shares absent
an effective registration statement under the Act and applicable state
securities law covering the disposition of such Warrants, without first
providing the Company with an opinion of counsel (which counsel and opinion are
reasonably satisfactory to the Company) to the effect that such transfer will be
exempt from the registration and the prospectus delivery requirements of the Act
and the registration or qualification requirements of any applicable U.S. state
securities laws.

     

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

     5.4.           Review of Company SEC
Documents.  Each Investor has reviewed the Company SEC
Documents, including the exhibits thereto.

     

     5.5.           No Value of Warrants on
Liquidation. Each Investor acknowledges and agrees that the Warrants will
become worthless if no Business Combination is consummated and the Investors
will have no recourse against Sellers as a result of such event.

     

     5.6.           Finders’ and Advisory
Fees. There is no investment banker, broker, finder or other intermediary
that has been retained by or is authorized to act on behalf of any Investor who
might be entitled to any fee or commission from the Company in connection with
the transactions contemplated in this Agreement.

     

    ARTICLE
6

     

    INDEMNIFICATION

     

     6.1.           Indemnification by
Sellers. From and after the date of this Agreement, Sellers, severally
and jointly (except with respect to the Several Provisions which shall be only
severally), shall indemnify, defend and hold harmless Investors, the Company and
their respective officers, directors, shareholders, employees, agents and
Affiliates and their successors and assigns against any loss, claim, damage,
cost, obligation, liability, penalty and expense, including all legal and other
expenses reasonably incurred in connection with investigating or defending
against any such loss, claim, damage, cost, obligation, liability, penalty or
expense or action in respect of such matters (collectively referred to as
“Indemnified Damages”), occasioned by, arising out of or resulting from any
breach or default of any representation or warranty by, or covenant of, such
Seller contained in this Agreement or any other agreement or
certificate  provided for in this Agreement or arising out of, or
resulting from, the operation of the Company by Sellers prior to the date hereof
to the extent that such claim is not covered by directors' and officers'
liability insurance maintained by the Company.

     

     6.2.           Indemnification by
Investors. From and after the date of this Agreement, Investors shall
indemnify, defend and hold harmless Sellers and their heirs, personal
representatives, agents, successors, and Affiliates against any Indemnified
Damages occasioned by, arising out of or resulting from any breach or default of
any representation or warranty by, or covenant of, Investors contained in this
Agreement or any other agreement provided for in this Agreement or arising out
of, or resulting from, the operation of the Company by Investors after the date
hereof to the extent that such claim is not covered by directors' and officers'
liability insurance maintained by the Company.

     

     6.3.           Notice of
Indemnification. Upon receipt by an indemnified party of notice of the
commencement against it of any action involving a claim, such indemnified party,
if a claim in respect of such action is to be made by it against any
indemnifying party under this Article 6, shall promptly notify in writing the
indemnifying party of such commencement.  In case any such action is
brought against any indemnified party, and it notifies an indemnifying party of
such commencement, the indemnifying party will be entitled to participate in the
defense and, to the extent that it may wish, jointly with any other indemnifying
party similarly notified, assume the defense of the action, with counsel
reasonably satisfactory to such indemnified party, and after notice from the
indemnifying party to such indemnified party of its election to assume the
defense, the indemnifying party will not be liable to such indemnified party
under this Article 6 for any legal or other expenses subsequently incurred by
such indemnified party in connection with the defense other than reasonable
costs of investigation.  Any such indemnifying party shall not be
liable to any such indemnified party on account of any settlement of any claim
or action effected without the written consent of such indemnifying
party.  The indemnifying party will not settle or compromise any claim
or action without the written consent of the indemnified party (which consent
shall not be unreasonably withheld).

     

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

     6.4.           Charter Protections;
Directors’ and Officers’ Liability Insurance.

     

    6.4.1  All
rights to indemnification for acts or omissions occurring through the date
hereof now existing in favor of any of the Sellers as provided in the Company’s
Amended and Restated Certificate of Incorporation and/or by-laws shall survive
the execution of this Agreement and the Closing and shall continue in full force
and effect in accordance with their terms.

     

    6.4.2  For
a period of either (i) six (6) years after the date hereof if the Company
consummates a Business Combination or (ii) three (3) years after the date hereof
if the Company dissolves and liquidates prior to the consummation of a Business
Combination, the Company shall cause to be maintained in effect the current
policies of directors' and officers' liability insurance maintained by the
Company (or policies of at least the same coverage and amounts containing terms
and conditions which are no less advantageous to the Sellers), with respect to
claims arising from facts and events that occurred through the date
hereof.

     

    6.4.3  If
the Company or any of its successors or assigns (i) consolidates with or merges
into any other Person and shall not be the continuing or surviving entity of
such consolidation or merger, or (ii) transfers or conveys all or substantially
all of its properties and assets to any Person, then, in each such case, to the
extent necessary, proper provision shall be made so that the successors and
assigns of the Company assume the obligations set forth in this Section
6.4.

     

    ARTICLE
7

     

    COVENANTS

     

     7.1.           No Creation of Liens with
Respect to Transferred Shares or Warrants. No Seller shall create or
allow to be created any Liens with respect to the Transferred Shares or
Warrants.

     

     7.2.           Release of Company and its
Officers and Directors.   Sellers hereby release the
Company and its officers, directors and shareholders from any claims
they may have now or in the future, whether contractual, statutory or
otherwise, against any of the Company, its officers, directors and
shareholders relating to the Company or its securities, including but not
limited to (i) the formation of the Company,  (ii) the operation of
the Company (including agreements between the Sellers and the Company) and
(iii) the dismissal of any Seller as an officer, director or employee of the
Company, if applicable.  Notwithstanding the foregoing, nothing herein
shall be construed as a waiver or release of (i) any claim for indemnification
that any Seller may have against the Company regardless of whether such claim
arises after the date hereof or (ii) any rights under this Agreement or any of
the agreements executed in connection herewith.

     

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

     

     7.3.           Assignment of Registration
Rights.   Sellers hereby conditionally assign to Investors
Sellers' rights and obligations under that certain Registration Rights Agreement
dated as of December 6, 2007 among the Company and each of the parties executing
a signature page thereto with respect to the Warrants, the shares of which stock
underlying the Warrants and the Transferred Shares, but shall retain all such
rights with respect to any Shares not being transferred to Sellers.

     

     7.4.           Delivery of
Records.  Promptly after the request of Investors, Sellers
shall deliver all of the Company’s organization documents, minute and stock
record books and the corporate seal, books of account, general, financial, tax
and personnel records, invoices, shipping records, supplier lists,
correspondence and other documents, records and files and computer software and
programs to Investors by delivering such documents to Mintz Levin Cohn Ferris
Glovsky & Popeo, P.C. or to such other place as may be requested by
Investors.  Sellers may retain copies of all of the
foregoing.

     

     7.5.           Form
10-K.  Ormand agrees to remain as the Company’s Co-Chief
Executive Officer and Chief Financial Officer until the Company’s Annual Report
on Form 10-K for the year ended December 31, 2008 is filed and to sign the
certifications attached as exhibits 31 and 32 thereto in his capacities as
Co-Chief Executive Officer and Chief Financial Officer.

     

     7.6.           Further Assurances.
Each party agrees that it will execute and deliver, or cause to be executed and
delivered, on or after the date of this Agreement, all such other documents and
instruments as are reasonably required for the performance of such party’s
obligations hereunder and will take all commercially reasonable actions as may
be necessary to consummate the transactions contemplated hereby and to
effectuate the provisions and purposes hereof.

     

    ARTICLE
8

     

    MISCELLANEOUS

     

     8.1.           Notices. All notices,
demands or requests provided for or permitted to be given pursuant to this
Agreement must be in writing and shall be delivered or sent, with the copies
indicated, by personal delivery, facsimile (with confirmation and additional
copy sent by overnight delivery service) or overnight delivery service (by a
reputable international carrier) to the parties as follows (or at such other
address as a party may specify by notice given pursuant to this
Section):

     

    
      To the
Sellers:                                                                Lawrence
S. Coben

      c/o Tremisis Energy Acquisition
Corporation II

      40 West 22nd Street, Suite
11

      New York, New York 10010

      Facsimile:
(212) 253-4047

       

      
        
          
          

        

        
          12

          
            

          

        

        
          
          

        

      

      

      and

      

      Ronald D.
Ormand

      2925
Briarpark, Suite 150-A

      Houston,
Texas  77042

      Facsimile:
(713) 963-5308

      

      To the
Company:                                                          Tremisis
Energy Acquisition Corporation II

      2925
Briarpark, Suite 150-A

      Houston,
Texas 77042

      Attention:
Ronald D. Ormand

      Facsimile:
(713) 963-5308

      

      In either
case, with a copy
to:                                      
Graubard Miller

      The
Chrysler Building

      405
Lexington Avenue

      New York,
New York 10174

      Attn:
David Alan Miller, Esq.

      Facsimile:
(212) 818-8881

      

      To
Investors:                                                                
 SoftForum Co., Ltd.

      (135-270)
7th
Floor, SoftForum B/D.

      545-7
Dogok-Dong,

      Gangnam-Gu,
Seoul 135-270 S. Korea

      Attention:
Sang-Chul Kim, Chairman

      Facsimile:
+82-2-526-8474

      

      With a
copy
to:                                                             
Mintz Levin Cohn Ferris Glovsky & Popeo, P.C.

      666 Third
Avenue

      New York,
New York  10017

      Attention:  Kenneth
R. Koch, Esq.

      Facsimile:
(212) 983-3115

    

    

    All
notices shall be deemed given and received one business day after their delivery
to the addresses for the respective party(ies), with the copies indicated, as
provided in this Section.

     

     8.2.           Entire Agreement.
This Agreement contains the sole and entire binding agreement among the parties
hereto with respect to the subject matter hereof and supersedes any and all
other prior written or oral agreements among them.

     

     8.3.           Amendment. No
amendment or modification of this Agreement shall be valid unless in writing and
duly executed by the parties affected by the amendment or
modification.

     

     8.4.           Binding Effect. This
Agreement shall be binding upon and inure to the benefit of the parties and
their respective representatives, heirs, successors and permitted
assigns.

     

    
      
        
        

      

      
        13

        
          

        

      

      
        
        

      

    

     

     8.5.           Waiver. Waiver by any
party of any breach of any provision of this Agreement shall not be considered
as or constitute a continuing waiver or a waiver of any other breach of the same
or any other provision of this Agreement.

     

     8.6.           Captions. The
captions contained in this Agreement are inserted only as a matter of
convenience or reference and in no way define, limit, extend or describe the
scope of this Agreement or the intent of any of its provisions.

     

     8.7.           Construction. In the
construction of this Agreement, whether or not so expressed, words used in the
singular or in the plural, respectively, include both the plural and the
singular and the masculine, feminine and neuter genders include all other
genders.  Since all parties have engaged in the drafting of this
Agreement, no presumption of construction against any party shall
apply.

     

     8.8.           Section References.
All references contained in this Agreement to Sections shall be deemed to be
references to Sections of this Agreement, except to the extent that any such
reference specifically refers to another document.  All references to
Sections shall be deemed to also refer to all subsections of such Sections, if
any.

     

     8.9.           Severability. In the
event that any portion of this Agreement is illegal or unenforceable, it shall
affect no other provisions of this Agreement, and the remainder of this
Agreement shall be valid and enforceable in accordance with its
terms.

     

     8.10.        
Assignment.
Neither this Agreement nor any rights under this Agreement may be assigned by
any party without the written consent of all other parties; provided, however,
Investors may assign this Agreement to an Affiliate or Affiliates of
Investors.

     

     8.11.         Governing Law. This
Agreement and the interpretation of its terms shall be governed by the laws of
the State of New York, without application of conflicts of law
principles.

     

     8.12.         Attorneys’ Fees. The
Company and the Investors shall pay their respective attorneys’ fees and
expenses for the negotiation and preparation of this Agreement and the other
agreements contemplated by this Agreement.

     

     8.13.         Public Disclosure. No
party to this Agreement shall make any public disclosure or publicity release
pertaining to the existence of the subject matter contained in this Agreement
without notifying and consulting with the other parties; provided, however, that
notwithstanding the foregoing, each party shall be permitted to make required
filings with the Securities and Exchange Commission.  With respect to
the press release and Form 8-K to be filed in connection with this transaction,
the Company shall provide the Sellers and Investors with a copy of such release
in advance and a reasonable opportunity to comment thereon.

     

     8.14.         Currency. All
monetary amounts in this Agreement are stated in United States dollars ($) and
shall be paid in that currency. No changes shall be made in any of such amounts
based upon changes in the value of the United States dollar against any other
currency.

     

    
      
        
        

      

      
        14

        
          

        

      

      
        
        

      

    

     

     8.15.         Execution in Counterparts;
Facsimile Signatures.  This Agreement and any amendment, waiver
or consent hereto may be executed by the parties hereto in separate
counterparts, each of which, when so executed and delivered, shall be an
original, but all such counterparts shall together constitute one and the same
instrument. All such counterparts may be delivered among the parties hereto by
facsimile or other electronic transmission, which shall not affect the validity
thereof.

     

     8.16.         Trust Fund
Waiver.  Each of SoftForum Co. Ltd. and Sang-Chul Kim hereby
waives any right, title, interest or claim of any kind in or to any monies in
the Company’s trust account (“Claim”), and each of SoftForum Co. Ltd. and
Sang-Chul Kim waives any Claim it may have in the future as a result of, or
arising out of, any negotiations, contracts or agreements with the Company and
will not seek recourse against the trust fund for any reason
whatsoever.

     

    [SIGNATURES
ON FOLLOWING PAGES]

     

    
      
        
        

      

      
        15

        
          

        

      

      
        
        

      

    

     

    The
parties have executed this Agreement as of the date set forth
above.

     

    
      
        
          
            
              
                
                  
                    	
                            SELLERS:

                          
	 
      
	/s/
      Lawrence
      S. Coben  
	
                            Lawrence
      S. Coben

                          
	 
      
	/s/
      Ronald
      D. Ormand
	
                            Ronald
      D. Ormand

                          
	 
      
	/s/
      Stephen
      N. Casati  
	
                            Stephen
      N. Casati

                          
	 
      
	/s/
      Jon
      Schotz  
	
                            Jon
      Schotz

                          
	 
      
	/s/ Charles
      A. Norris
	
                            Charles
      A. Norris

                          
	 
      
	/s/
      Bill
      Armstrong
	
                            Bill
      Armstrong

                          

                  

                

              

            

          

        

      

    

    

    
      
        
          
            
              
                
                  
                    
                      	
                              OLYMPUS
      CAPITAL INVESTMENT, LLC

                            
	 
      	 
      
	
                              By:

                            	/s/
      Dean Vanech  
	 
      	
                              Dean
      Vanech, Member

                            
	 
      	 
      
	/s/
      Jerry
      Doren  
	
                              Jerry
      Doren

                            
	 
      
	/s/
      Owen
      Coleman  
	
                              Owen
      Coleman

                            
	 
      
	/s/
      Bill
      Goldstein  
	
                              Bill
      Goldstein

                            
	 
      
	/s/
      Trevor
      Wilson  
	
                              Trevor
      Wilson

                            
	 
      
	/s/
      David
      A. Preiser  
	
                              David
      A. Preiser

                            
	 
      
	/s/
      Brian
      McInerney  
	
                              Brian
      McInerney

                            

                    

                  

                

              

            

          

        

      

    

     

    
      
        
        

      

      
        16

        
          

        

      

      
        
        

      

    

    

    
      
        
          
            
              
                
                  	/s/
      Richard
      Kassar  
	
                          Richard
      Kassar

                        
	 
      
	/s/
      David
      Levine  
	
                          David
      Levine

                        
	 
      
	/s/
      Jim
      Land  
	
                          Jim
      Land

                        
	 
      
	/s/
      Jonathan
      Jacobs  
	
                          Jonathan
      Jacobs

                        
	 
      
	/s/
      Gary
      C. Evans  
	
                          Gary
      C.
Evans

                        

                

              

            

          

        

      

    

    

    
      
        
          
            
              	
                      COMPANY:

                    
	 
      
	
                      TREMISIS ENERGY ACQUISITION CORPORATION
      II

                    
	 
      
	
                      By:

                    	/s/
      Lawrence S. Coben
	
                      Name:

                    	Lawrence
      S. Coben
	
                      Title:

                    	Chief
      Executive Officer
	 
      	 
      
	
                      INVESTORS:

                    
	 
      
	
                      SOFTFORUM
      CO., LTD.

                    
	 
      	 
      
	
                      By:

                    	/s/
      Sang-Chul Kim  
	
                      Name:

                    	Sang-Chul
      Kim  
	
                      Title:

                    	Chairman
	 
      	 
      
	/s/
      Sang-Chul
      Kim  
	
                      Sang-Chul
      Kim

                    

            

          

        

      

    

    

    
      
        
        

      

      
        17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]